[Form 4] CompoSecure, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kevin M. Moriarty, identified in the filing as a director of CompoSecure, Inc. (CMPO), purchased 13,000 shares of Class A common stock on 08/13/2025 at a weighted average price of $19.28 per share. The Form 4 reports the purchases were made in multiple transactions at prices ranging from $19.10 to $19.30, and the reporting person holds 13,000 shares following these trades. The filing was submitted by a single reporting person and records the holdings as direct beneficial ownership. No derivative securities are listed in the report, and the filer states they will provide a per-price breakdown on request.

Positive

• Director purchase: Kevin M. Moriarty acquired 13,000 Class A shares, demonstrating insider buying activity.
• Transparent pricing disclosure: Filing reports a weighted average price of $19.28 and discloses the trade price range of $19.10–$19.30.
• No derivatives reported: Table II is blank, indicating the transaction involved only common stock and direct ownership.

Negative

• None.

Insights

Financial Analyst

TL;DR Director Kevin Moriarty bought 13,000 CMPO shares at a weighted average of $19.28; a clear insider purchase but likely not materially transformational.

The purchase represents direct buying by a board member and was executed across multiple trades between $19.10 and $19.30, producing a weighted average of $19.28. This is a straightforward open-market acquisition recorded on Form 4. While insider purchases can signal alignment with shareholders, the filing does not disclose company-level figures or relative stake size, so materiality to valuation cannot be assessed from the form alone.

Corporate Governance Expert

TL;DR Form 4 shows compliant, transparent reporting of a director's open-market purchase with an offered breakdown of transaction prices.

The form indicates the reporter filed individually and recorded direct beneficial ownership of 13,000 shares. Table II (derivatives) is empty, suggesting no options or warrants were transacted or held as part of this filing. The statement that the filer will provide a detailed per-price breakdown on request reflects procedural transparency and responsiveness to SEC or shareholder inquiries.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moriarty Kevin M

(Last) (First) (Middle)

C/O COMPOSECURE, INC.

309 PIERCE STREET

(Street)

SOMERSET NJ 08873

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CompoSecure, Inc. [ CMPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/13/2025		P		13,000	A	$19.28(1)	13,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.10 to $19.30, inclusive. The reporting person undertakes to provide CompoSecure, Inc. (the "Issuer"), any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Remarks:

	/s/ Kevin M. Moriarty, by attorney-in-fact Steven J. Feder	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did CompoSecure (CMPO) report on Form 4?

Kevin M. Moriarty purchased 13,000 shares of Class A common stock on 08/13/2025 at a weighted average price of $19.28 per share.

Who is the reporting person on the CMPO Form 4?

The reporting person is Kevin M. Moriarty, identified in the filing as a director of CompoSecure, Inc.

How were the CMPO shares purchased and at what prices?

The filing states the shares were purchased in multiple transactions at prices ranging from $19.10 to $19.30, yielding a weighted average of $19.28.

How many CMPO shares does the reporting person own after the transaction?

Following the reported transactions, the filing shows the reporting person beneficially owns 13,000 shares, held directly.

Were any derivative securities reported in the Form 4 for CMPO?

No. Table II lists no derivative securities, indicating no options, warrants, or convertible instruments were reported in this filing.